Literature DB >> 23918945

Sirolimus reduces cutaneous squamous cell carcinomas in transplantation recipients.

Oscar R Colegio1, Allison Hanlon, Edit B Olasz, John A Carucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23918945     DOI： 10.1200/JCO.2013.50.6840

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  The cutting edge of skin cancer in transplant recipients: scientific retreat of international transplant Skin Cancer Collaborative and Skin Cancer in Organ Transplant Patients Europe.

Authors:  A Hanlon; O R Colegio
Journal:  Am J Transplant       Date:  2014-03-10       Impact factor: 8.086

Review 2.  Keratinocyte Carcinomas: Current Concepts and Future Research Priorities.

Authors:  Priyadharsini Nagarajan; Maryam M Asgari; Adele C Green; Samantha M Guhan; Sarah T Arron; Charlotte M Proby; Dana E Rollison; Catherine A Harwood; Amanda Ewart Toland
Journal:  Clin Cancer Res       Date:  2018-12-06       Impact factor: 12.531

3.  Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22.

Authors:  Melody Abikhair; Hiroshi Mitsui; Valerie Yanofsky; Nazanin Roudiani; Channa Ovits; Teddy Bryan; Tatiana M Oberyszyn; Kathleen L Tober; Juana Gonzalez; James G Krueger; Diane Felsen; John A Carucci
Journal:  JCI Insight       Date:  2016-06-02

Review 4.  Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients.

Authors:  J R Bank; T J Rabelink; J W de Fijter; M E J Reinders
Journal:  J Immunol Res       Date:  2015-07-15       Impact factor: 4.818

5.  Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.

Authors:  André Pinho; Miguel Gouveia; José Carlos Cardoso; Maria Manuel Xavier; Ricardo Vieira; Rui Alves
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.